Even after the FDA warned that anemia drugs like Aranesp, Epogen and Procrit could increase the risk of death among patients, for-profit dialysis centers continued to use them more than…
Amgen has agreed to pay $762 million to settle a whistleblower lawsuit and criminal charges this week, which allege that the drug maker illegally promoted their anemia medications Aranesp and…
Three popular anemia drugs, Epogen, Procrit and Aranesp, may be far less effective, and far more dangerous, than their manufacturer led the public and experts to believe, according to an…
According to the findings of a new study, Anemia drugs like Epogen and Aranesp, are being widely misused.
The increased risk of heart problems, strokes and death from Aranesp, Procrit and Epogen has led federal health regulators to urge doctors to be cautious with certain users of the…
The findings of recent research suggest that using the anemia drugs Epogen and Procrit following a heart attack is not only ineffective, but may cause further heart damage.
Federal drug safety reviewers are evaluating the potential risk of rare and sometimes fatal skin reactions known as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) among users of the…
Despite a potential risk of stroke associated with the use of Aranesp, Procrit and Epogen, an FDA advisory panel has indicated that the anemia drugs are safe to use to…
A recall of Epogen and Procrit vials has been issued due to a risk that certain lots of the anemia drugs may be contaminated with small glass flakes that could…
The findings of a new study indicate that people with chronic kidney disease and diabetes who respond poorly to certain anemia drugs may face an increased risk of cardiovascular problems…
